Year 2020 / Volume 112 / Number 9
Original
Sentinel lymph node mapping for metastasis detection in colorectal cancer: a systematic review and meta-analysis

722-730

DOI: 10.17235/reed.2020.6767/2019

Likui Qiao,

Abstract
Introduction: controversy exists on the diagnostic performance of sentinel lymph node (SLN) mapping in colorectal cancer. This study aimed to provide a more precise estimation of its clinical significance. Materials and methods: a systematic search of electronic databases was conducted to retrieve all relevant studies up to August 31st, 2019. Detection rate, sensitivity, and upstaging rate were pooled together, and a subgroup analysis was performed to identify factors that affect diagnostic performance. The prognostic value of upstaging was also explored. Results: sixty-eight studies were eligible and included. The pooled SLN detection rate was 0.93 (95 % CI, 0.91-0.94), with a significant higher rate in colon cancer or in studies including more than 100 patients. The overall sensitivity of the SLN procedure in colorectal cancer was 0.72 (95 % CI, 0.67-0.77). The tracers used were found to influence sensitivity. A mean weighted upstaging of 0.22 (95 % CI, 0.18-0.25) was identified. True upstaging, defined as micro-metastases, was 14 %. Upstaged patients were associated with worse overall survival (OS) when compared with node-negative patients (HR = 2.60, 95 % CI, 0.16-4.63). In addition, upstaged patients had a lower 5-year disease-free survival (DFS) rate than node-negative patients. Conclusion: based on the results of the present meta-analysis, the SLN mapping procedure should focus on early stage patients to refine staging, since upstaging appeared to be a prognostic factor for DFS and OS. The SLN procedure can be recommended for colorectal cancer patients in addition to conventional resection.
Share Button
New comment
Comments
No comments for this article
References
1. Siegel R, DeSantis C, Jemal A. Colorectal cancer statistics, 2014. CA: A Cancer Journal for Clinicians. 2014;64(2):104-117.doi:10.3322/caac.21220.
2. Figueredo A, Coombes ME, Mukherjee S. Adjuvant Therapy for completely resected Stage II Colon Cancer. Cochrane Database of Systematic Reviews. 2008(3).doi:10.1002/14651858.CD005390.pub2.
3. Cohen AM, Kelsen D, Saltz L, et al. Adjuvant therapy for colorectal cancer. Current Problems in Surgery. 1997;34(8):601-676.doi:https://doi.org/10.1016/S0011-3840(97)80013-5.
4. Weixler B, Warschkow R, Güller U, et al. Isolated tumor cells in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survival. BMC Cancer. 2016;16(1):106.doi:10.1186/s12885-016-2130-7.
5. Mescoli C, Albertoni L, Pucciarelli S, et al. Isolated Tumor Cells in Regional Lymph Nodes as Relapse Predictors in Stage I and II Colorectal Cancer. Journal of Clinical Oncology. 2012;30(9):965-971.doi:10.1200/jco.2011.35.9539.
6. Saha S, Elgamal M, Cherry M, et al. Challenging the conventional treatment of colon cancer by sentinel lymph node mapping and its role of detecting micrometastases for adjuvant chemotherapy. Clinical & Experimental Metastasis. 2018;35(5):463-469.doi:10.1007/s10585-018-9927-5.
7. Hermanek P, Hutter RV, Sobin LH, et al. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer. 1999;86(12):2668-2673.
8. Braat AE, Oosterhuis JW, de Vries JE, et al. Lymphatic staging in colorectal cancer: pathologic, molecular, and sentinel node techniques. Diseases of the colon and rectum. 2005;48(2):371-383.doi:10.1007/s10350-004-0796-4.
9. Borgstein PJMD, Pijpers RMD, Comans EFMD, et al. Sentinel Lymph Node Biopsy in Breast Cancer: Guidelines and Pitfalls of Lymphoscintigraphy and Gamma Probe Detection. Journal of the American College of Surgeons. 1998;186(3):275-283.doi:10.1016/S1072-7515(98)00011-8.
10. Koyanagi K, Bilchik AJ, Saha S, et al. Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. Clin Cancer Res. 2008;14(22):7391-7396.doi:10.1158/1078-0432.CCR-08-0290.
11. Whiting P, Rutjes AWS, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25-25.doi:10.1186/1471-2288-3-25.
12. Albayrak Y, Oren D, Gundogdu C, et al. Intraoperative sentinel lymph node mapping in patients with colon cancer: study of 38 cases. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology. 2011;22(3):286-292.doi:10.4318/tjg.2011.0214.
13. Andersen HS, Bennedsen ALB, Burgdorf SK, et al. In vivo and ex vivo sentinel node mapping does not identify the same lymph nodes in colon cancer. Int J Colorectal Dis. 2017;32(7):983-990.doi:10.1007/s00384-017-2777-9.
14. Bartels SAL, van der Zaag ES, Dekker E, et al. The effect of colonoscopic tattooing on lymph node retrieval and sentinel lymph node mapping. Gastrointestinal Endoscopy. 2012;76(4):793-800.doi:10.1016/j.gie.2012.05.005.
15. Bell SW, Mourra N, Flejou JF, et al. Ex vivo sentinel lymph node mapping in colorectal cancer. Diseases of the colon and rectum. 2005;48(1):74-79.doi:10.1007/s10350-004-0782-x.
16. Bembenek A, Rau B, Moesta T, et al. Sentinel lymph node biopsy in rectal cancer&x2014;Not yet ready for routine clinical use. Surgery. 2004;135(5):498-505.doi:10.1016/j.surg.2003.10.004.
17. Bembenek AE, Rosenberg R, Wagler E, et al. Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg. 2007;245(6):858-863.doi:10.1097/01.sla.0000250428.46656.7e.
18. Bertagnolli M, Miedema B, Redston M, et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann Surg. 2004;240(4):624-630.doi:10.1097/01.sla.0000140753.41357.20.
19. Bertoglio S, Sandrucci S, Percivale P, et al. Prognostic value of sentinel lymph node biopsy in the pathologic staging of colorectal cancer patients. Journal of Surgical Oncology. 2004;85(3):166-170.doi:10.1002/jso.20030.
20. Bianchi PP, Petz W, Casali L. Laparoscopic lymphatic roadmapping with blue dye and radioisotope in colon cancer. Colorectal Disease. 2011;13(s7):67-69.doi:10.1111/j.1463-1318.2011.02786.x.
21. Bilchik AJ, Nora DT, Sobin LH, et al. Effect of Lymphatic Mapping on the New Tumor-Node-Metastasis Classification for Colorectal Cancer. Journal of Clinical Oncology. 2003;21(4):668-672.doi:10.1200/jco.2003.04.037.
22. Broderick-Villa G, Ko A, O'Connell TX, et al. Does tumor burden limit the accuracy of lymphatic mapping and sentinel lymph node biopsy in colorectal cancer? Cancer journal (Sudbury, Mass.). 2002;8(6):445-450.doi:10.1097/00130404-200211000-00008.
23. Chan SH, Ng C, Looi LM. Intraoperative methylene blue sentinel lymph node mapping in colorectal cancer. ANZ journal of surgery. 2008;78(9):775-779.doi:10.1111/j.1445-2197.2008.04648.x.
24. Codignola C, Zorzi F, Zaniboni A, et al. Is there any Role for Sentinel Node Mapping in Colorectal Cancer Staging? Personal Experience and Review of the Literature. Japanese Journal of Clinical Oncology. 2005;35(11):645-650.doi:10.1093/jjco/hyi182.
25. Cox ED, Kellicut D, Adair C, et al. Sentinel lymph node evaluation is technically feasible and may improve staging in colorectal cancer. Current surgery. 2002;59(3):301-306.doi:10.1016/s0149-7944(01)00639-0.
26. Cserni G, Vajda K, Tarjan M, et al. Nodal staging of colorectal carcinomas from quantitative and qualitative aspects. Can lymphatic mapping help staging? Pathology oncology research : POR. 1999;5(4):291-296.doi:10.1053/paor.1999.0205.
27. Currie AC, Brigic A, Thomas-Gibson S, et al. A pilot study to assess near infrared laparoscopy with indocyanine green (ICG) for intraoperative sentinel lymph node mapping in early colon cancer. European Journal of Surgical Oncology. 2017;43(11):2044-2051.doi:10.1016/j.ejso.2017.05.026.
28. Dahl K, Westlin J, Kraaz W, et al. Identification of sentinel nodes in patients with colon cancer. European Journal of Surgical Oncology. 2005;31(4):381-385.doi:10.1016/j.ejso.2004.12.015.
29. de Haas RJ, Wicherts DA, Hobbelink MGG, et al. Sentinel lymph node mapping in colon cancer using radiocolloid as a single tracer: a feasibility study. Nuclear Medicine Communications. 2012;33(8):832-837.doi:10.1097/MNM.0b013e328353bc0c.
30. Demirbas S, Ince M, Baloglu H, et al. Should sentinel lymph node mapping be performed for colorectal cancer? The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology. 2004;15(1):39-44.
31. Esser S, Reilly WT, Riley LB, et al. The role of sentinel lymph node mapping in staging of colon and rectal cancer. Diseases of the colon and rectum. 2001;44(6):850-854; discussion 854-856.doi:10.1007/bf02234707.
32. Estrada O, Pulido L, Admella C, et al. Sentinel lymph node biopsy as a prognostic factor in non-metastatic colon cancer: a prospective study. Clinical and Translational Oncology. 2017;19(4):432-439.doi:10.1007/s12094-016-1543-8.
33. Faerden AE, Sjo OH, Andersen SN, et al. Sentinel node mapping does not improve staging of lymph node metastasis in colonic cancer. Diseases of the colon and rectum. 2008;51(6):891-896.doi:10.1007/s10350-007-9185-0.
34. Finan KR, Lewis JS, Jr., Winslow E, et al. Ex vivo sentinel lymph node mapping in patients undergoing proctectomy for rectal cancer. Diseases of the colon and rectum. 2010;53(3):243-250.doi:10.1007/DCR.0b013e3181c3822b.
35. Gandy CP, Biddlestone LR, Roe AM, et al. Intra-operative injection of Patent Blue V dye to facilitate nodal staging in colorectal cancer. Colorectal Disease. 2002;4(6):447-449.doi:10.1046/j.1463-1318.2002.00391.x.
36. Hirche C, Mohr Z, Kneif S, et al. Ultrastaging of colon cancer by sentinel node biopsy using fluorescence navigation with indocyanine green. Int J Colorectal Dis. 2012;27(3):319-324.doi:10.1007/s00384-011-1306-5.
37. Ivanov K, Kolev N, Ignatov V, et al. Intraoperative sentinel lymph node mapping in patients with colorectal cancer. Hepato-gastroenterology. 2009;56(89):99-105.
38. Joosten JJA, Strobbe LJA, Wauters CAP, et al. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. BJS (British Journal of Surgery). 1999;86(4):482-486.doi:10.1046/j.1365-2168.1999.01051.x.
39. Kelder W, Braat AE, Karrenbeld A, et al. The sentinel node procedure in colon carcinoma: a multi-centre study in The Netherlands. Int J Colorectal Dis. 2007;22(12):1509-1509.doi:10.1007/s00384-007-0351-6.
40. Khafagy W, El-Dawoody A, El-Ghawalby N, et al. Ultrastaging of Rectal Cancer Based on Identification of Micrometastases in Sentinel Lymph Node. coloproctology. 2005;27(3):153-160.doi:10.1007/s00053-005-5164-x.
41. Kitagawa Y, Watanabe M, Hasegawa H, et al. Sentinel node mapping for colorectal cancer with radioactive tracer. Diseases of the colon and rectum. 2002;45(11):1476-1480.doi:10.1007/s10350-004-6453-0.
42. Koksal H, Bostanci H, Mentes BB. Importance of sentinel lymph nodes in colorectal cancer: a pilot study. Advances in therapy. 2007;24(3):583-588.doi:10.1007/bf02848781.
43. Kusano M, Tajima Y, Yamazaki K, et al. Sentinel Node Mapping Guided by Indocyanine Green Fluorescence Imaging: A New Method for Sentinel Node Navigation Surgery in Gastrointestinal Cancer. Digestive Surgery. 2008;25(2):103-108.doi:10.1159/000121905.
44. Liberale G, Lasser P, Sabourin JC, et al. Sentinel lymph nodes of colorectal carcinoma: reappraisal of 123 cases. Gastroenterologie clinique et biologique. 2007;31(3):281-285.doi:10.1016/s0399-8320(07)89374-2.
45. Lim SJ, Feig BW, Wang H, et al. Sentinel Lymph Node Evaluation Does Not Improve Staging Accuracy in Colon Cancer. Annals of Surgical Oncology. 2008;15(1):46-51.doi:10.1245/s10434-007-9629-8.
46. Matter M, Winckler M, Aellen S, et al. Detection of metastatic disease with sentinel lymph node dissection in colorectal carcinoma patients. European Journal of Surgical Oncology. 2007;33(10):1183-1190.doi:10.1016/j.ejso.2007.03.019.
47. Merrie AE, van Rij AM, Phillips LV, et al. Diagnostic use of the sentinel node in colon cancer. Diseases of the colon and rectum. 2001;44(3):410-417.doi:10.1007/bf02234742.
48. Murawa D, Filas V, Breborowicz J, et al. Evaluation of the sentinel node biopsy in colorectal carcinoma including the results of immunohistochemical examinations. Acta chirurgica Belgica. 2007;107(1):45-48.doi:10.1080/00015458.2007.11680009.
49. Nordgård O, Oltedal S, Aasprong OG, et al. Prognostic Relevance of Occult Metastases Detected by Cytokeratin 20 and Mucin 2 mRNA Levels in Sentinel Lymph Nodes from Colon Cancer Patients. Annals of Surgical Oncology. 2012;19(12):3719-3726.doi:10.1245/s10434-012-2454-8.
50. Oh SY, Kim DY, Kim YB, et al. Clinical application of sentinel lymph node mapping in colon cancer: in vivo vs. ex vivo techniques. Ann Surg Treat Res. 2014;87(3):118-122.doi:10.4174/astr.2014.87.3.118.
Related articles

Letter

Vaginal lesion as first manifestation of colorectal disease

DOI: 10.17235/reed.2022.9270/2022

Letter

Intra-abdominal epithelioid angiosarcoma

DOI: 10.17235/reed.2022.8878/2022

Letter

Cytomegalovirus colitis seems to be colon cancer. HIV debut

DOI: 10.17235/reed.2022.8699/2022

Letter

Sigmoid colon Schwannoma simulating colon cancer

DOI: 10.17235/reed.2022.8684/2022

Letter

Unexpected diagnosis for nodular hepatic lesions

DOI: 10.17235/reed.2021.8230/2021

Review

Inflammatory bowel disease and solid organ transplantation

DOI: 10.17235/reed.2020.7361/2020

Review

New non-invasive biomarkers for colorectal cancer screening

DOI: 10.17235/reed.2020.7233/2020

Letter

Medullary colorectal carcinoma. Do we really know it?

DOI: 10.17235/reed.2020.6728/2019

Letter

Signet ring cell carcinoma in a juvenile polyp

DOI: 10.17235/reed.2019.6299/2019

Letter

The rectosigmoid junction: are limits important?

DOI: 10.17235/reed.2019.5983/2018

Editorial

Colorectal cancer screening and survival

DOI: 10.17235/reed.2018.5870/2018

Letter to the Editor

Liver metastasis from colorectal cancer 12 years after liver transplantation

DOI: 10.17235/reed.2017.4507/2016

Review

Serrated lesions and serrated polyposis syndrome

DOI: 10.17235/reed.2017.4065/2015

Letter to the Editor

Endobronchial metastases of colorectal cancer

DOI: 10.17235/reed.2016.4080/2015

Case Report

Primary squamous cell carcinoma of the rectum: an atypical histology

DOI: 10.17235/reed.2016.3975/2015

Citation tools
Qiao L. Sentinel lymph node mapping for metastasis detection in colorectal cancer: a systematic review and meta-analysis. 6767/2019


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 677 visits.
This article has been downloaded 169 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 25/11/2019

Accepted: 11/03/2020

Online First: 07/09/2020

Published: 10/09/2020

Article revision time: 92 days

Article Online First time: 287 days

Article editing time: 290 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology